SCHEMBL6817658

SCHEMBL6817658

COc1ccc(OC)c2c1CC(CN)(CC(=O)O)C2

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.42
TSHR P16473 3/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
LMNA P02545 2/20 0.42
USP2 O75604 1/20 0.42
CYP1A2 P05177 1/20 0.42
BLM P54132 1/20 0.42
CACNA2D1 P54289 1/20 0.42
GAA P10253 3/20 0.40
HSD17B10 Q99714 2/20 0.40
TDP1 Q9NUW8 2/20 0.36
NFKB1 P19838 1/20 0.36
ADRA1A P35348 1/20 0.36
HPGD P15428 3/20 0.36
POLB P06746 1/20 0.36
CA5A P35218 1/20 0.35
KDM4E B2RXH2 2/20 0.35
HTT P42858 1/20 0.35
MAPT P10636 1/20 0.35
CA12 O43570 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6818043 0.86 ALDH1A1 (0.39) ALDH1A1TSHRSMN1; SMN2LMNAUSP2
SCHEMBL6817239 0.81 ALDH1A1 (0.42) ALDH1A1TSHRSMN1; SMN2LMNAUSP2
SCHEMBL6818099 0.79 ALDH1A1 (0.46) ALDH1A1TSHRSMN1; SMN2LMNAUSP2
SCHEMBL6821612 0.76 ALDH1A1 (0.46) ALDH1A1TSHRSMN1; SMN2LMNAUSP2
SCHEMBL6813342 0.76 ALDH1A1 (0.46) ALDH1A1TSHRSMN1; SMN2LMNAUSP2
SCHEMBL6818053 0.75 ALDH1A1 (0.42) ALDH1A1TSHRSMN1; SMN2LMNAUSP2
SCHEMBL6817230 0.74 ALDH1A1 (0.43) ALDH1A1TSHRSMN1; SMN2LMNAUSP2
SCHEMBL6821003 0.74 HPGD (0.39) ALDH1A1TSHRSMN1; SMN2LMNAUSP2
SCHEMBL9828092 0.73 RBP1 (0.40) ALDH1A1TSHRSMN1; SMN2LMNACYP1A2
SCHEMBL6813480 0.73 TRPA1 (0.39) ALDH1A1TSHRSMN1; SMN2LMNAUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1180094-B1 FUSED POLYCYCLIC AMINO ACIDS AS PHARMACEUTICAL AGENTS WARNER LAMBERT CO (US) 2004-07-28 EP claimed
EP-1180094-A1 FUSED POLYCYCLIC AMINO ACIDS AS PHARMACEUTICAL AGENTS WARNER-LAMBERT COMPANY (US) 2002-02-20 EP claimed
WO-2000073259-A1 FUSED POLYCYCLIC AMINO ACIDS AS PHARMACEUTICAL AGENTS WARNER-LAMBERT COMPANY (US) 2000-12-07 WO claimed
WO-2007090661-A2 ACTIVE SUBSTANCE COMBINATION COMPRISING AZOLYLCARBINOL COMPOUNDS LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2007-08-16 WO disclosed
EP-1180094-B1 FUSED POLYCYCLIC AMINO ACIDS AS PHARMACEUTICAL AGENTS WARNER LAMBERT CO (US) 2004-07-28 EP disclosed
EP-1180094-A1 FUSED POLYCYCLIC AMINO ACIDS AS PHARMACEUTICAL AGENTS WARNER-LAMBERT COMPANY (US) 2002-02-20 EP disclosed
WO-2000073259-A1 FUSED POLYCYCLIC AMINO ACIDS AS PHARMACEUTICAL AGENTS WARNER-LAMBERT COMPANY (US) 2000-12-07 WO disclosed